Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0611702127659574 0.0425531914893617 0 0
Stock impact report

Oragenics CEO Murphy Leaves, President Redmond Named Interim Replacement [MarketWatch]

Oragenics Inc. (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
Company Research Source: MarketWatch
The development-stage pharmaceutical company focused on nasal delivery of medications in neurology and infectious diseases on Monday said Murphy, who joined the board in 2020, will continue as a board director. Advertisement During the transition, Chairman Charlie Pope will serve as interim executive chairman. The agreement provides Murphy with the benefits under her employment agreement for a separation without cause. Murphy's resignation as an officer was not due to any disagreement with Oragenics on any matter related to its operations, policies or practices, the company added. Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix Show less Read more
Impact Snapshot
Event Time:
OGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
OGEN alerts

from News Quantified
Opt-in for
OGEN alerts

from News Quantified